Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Global Cord Blood Corporation (CO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
2.5500-0.1300 (-4.85%)
At close: 04:00PM EDT
2.5200 -0.03 (-1.18%)
After hours: 04:28PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.6800
Open2.7000
Bid2.5800 x 900
Ask3.1000 x 800
Day's Range2.5500 - 2.7235
52 Week Range2.1000 - 6.3100
Volume70,399
Avg. Volume146,851
Market Cap309.955M
Beta (5Y Monthly)0.33
PE Ratio (TTM)3.91
EPS (TTM)0.6530
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJul 31, 2018
1y Target EstN/A
  • PR Newswire

    Global Cord Blood Corporation Announces Receipt of Blue Ocean Petition

    Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, announced today that the Company has received a copy of a petition that was filed with the Grand Court of the Cayman Islands by Blue Ocean Structure Investment Company Limited ("Blue Ocean"). The Company is taking legal advice in response to Blue Ocean's petition and will make further announcem

  • PR Newswire

    Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products Rights

    Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, announced today that the Company will acquire 100% of Cellenkos, Inc ("CLNK") and the rights to develop and commercialize all of its existing and future products worldwide except those related to CLNK's existing collaboration with Incyte Corporation (Nasdaq: INCY, "Incyte"). As of the date here

  • GlobeNewswire

    Disposal by Casino Group of its remaining stake in Mercialys

    Disposal by Casino Group of its remaining stake in Mercialys Paris, 4th April 2022, Following the disposal of 6.5% of Mercialys equity through a total return swap (TRS) concluded on February 21st 2022 (and now settled), Casino Group today completed the disposal of its remaining stake in Mercialys, i.e. 10.3% of Mercialys equity, through a new TRS.Following this transaction, Casino Group no longer holds any voting rights in Mercialys. Proceeds of the transaction amount to €86 million. ANALYST AND

Advertisement
Advertisement